Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback